Literature DB >> 28133987

Ruptured intracranial vertebral artery dissecting aneurysms: An evaluation of prognostic factors of treatment outcome.

K Urasyanandana1, P Withayasuk2, D Songsaeng2, T Aurboonyawat2, E Chankaew2, A Churojana2.   

Abstract

Objective Intracranial spontaneous vertebral artery dissecting aneurysms commonly occur in the third to fifth decades of life, and are mostly associated with hypertension. Patients present with intracranial haemorrhage or thromboembolic events. Patients who present with intracranial haemorrhage carry about a 70% risk of recurrent bleeding. Patients with a posterior-inferior cerebellar artery (PICA) or ipsilateral dominant vertebral artery involve selecting which parent vessel could not be sacrificed. Recent reconstructive techniques such as stent-assisted coiling embolisation and flow-diverting stents are effective treatments of choice. Methods Seventeen patients presented subarachnoid haemorrhage and nine patients with other symptoms. Sacrificing the parent vertebral artery was the first choice for surgical or endovascular methods. Endovascular reconstructive treatment by stent-assisted coiling embolisation was indicated in dissecting vertebral artery aneurysms with ipsilateral dominant vertebral artery or PICA involvement. Clinical outcomes were determined using the modified Rankin Score (mRS) at 90 days, with favourable outcomes defined as 0 to 2. Results Of the patients presenting with ruptured aneurysms, 11 (61.1%) had a good clinical outcome, with a mRS of 0-2. Favourable Hunt and Hess grading (65%), mild to moderate GCS (65%) and total occlusion of aneurysms after treatment (65%) were significantly good prognostic factors in patients with ruptured vertebral artery dissecting aneurysms. Conclusion Endovascular parent vessel sacrifice could be the first choice to treat a ruptured vertebral artery dissecting aneurysm. Stent-assisted coiling to preserve the patency of the parent artery and its branches is a promising treatment for vertebral artery dissections.

Entities:  

Keywords:  Dissecting aneurysm; ruptured aneurysm; vertebral artery

Mesh:

Year:  2017        PMID: 28133987      PMCID: PMC5490857          DOI: 10.1177/1591019917691252

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  41 in total

Review 1.  The many faces of intracranial arterial dissections.

Authors:  T Krings; I-S Choi
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

2.  Management of ruptured and unruptured intracranial vertebral artery dissecting aneurysms.

Authors:  Wandong Su; Shouzhong Gou; Shilei Ni; Gang Li; Yuguang Liu; Shugan Zhu; Xingang Li
Journal:  J Clin Neurosci       Date:  2011-10-21       Impact factor: 1.961

3.  Endovascular treatment using stents for vertebral artery fusiform aneurysms.

Authors:  Xianli Lv; Youxiang Li; Chuhan Jiang; Xinjian Yang; Zhongxue Wu
Journal:  Neurol Res       Date:  2010-05-04       Impact factor: 2.448

4.  Vertebral artery occlusion with vertebral artery-to-posterior inferior cerebellar artery stenting for preservation of the PICA in treating ruptured vertebral artery dissection.

Authors:  Joonho Chung; Bum-soo Kim; Dongwoo Lee; Tae-Hyun Kim; Yong Sam Shin
Journal:  Acta Neurochir (Wien)       Date:  2010-07-01       Impact factor: 2.216

5.  Outcomes and prognostic factors of intracranial unruptured vertebrobasilar artery dissection.

Authors:  B M Kim; S H Kim; D I Kim; Y S Shin; S H Suh; D J Kim; S I Park; K Y Park; S S Ahn
Journal:  Neurology       Date:  2011-05-17       Impact factor: 9.910

Review 6.  Dissecting aneurysms of the intracranial vertebral artery.

Authors:  A Yamaura; Y Watanabe; N Saeki
Journal:  J Neurosurg       Date:  1990-02       Impact factor: 5.115

7.  Treatment of spontaneous intradural vertebral artery dissections.

Authors:  T Nakazawa; Y Takeichi; T Yokoi; T Fukami; J Jito; N Nitta; K Takagi; K Nozaki
Journal:  Neuroradiol J       Date:  2011-10-24

8.  Reconstructive endovascular treatment of a ruptured vertebral artery dissecting aneurysm using the Pipeline embolization device.

Authors:  Andrew F Ducruet; R Webster Crowley; Felipe C Albuquerque; Cameron G McDougall
Journal:  J Neurointerv Surg       Date:  2012-06-20       Impact factor: 5.836

9.  Intracranial vertebral artery dissection with subarachnoid hemorrhage: clinical characteristics and outcomes in conservatively treated patients.

Authors:  Masaru Yamada; Takao Kitahara; Akira Kurata; Kiyotaka Fujii; Yoshio Miyasaka
Journal:  J Neurosurg       Date:  2004-07       Impact factor: 5.115

10.  Use of the sole stenting technique for the management of aneurysms in the posterior circulation in a prospective series of 20 patients.

Authors:  Marco Antonio Zenteno; Jorge Arturo Santos-Franco; Jose Maria Freitas-Modenesi; Camilo Gómez; Luis Murillo-Bonilla; Yolanda Aburto-Murrieta; Ricardo Díaz-Romero; Edgar Nathal; Sergio Gómez-Llata; Angel Lee
Journal:  J Neurosurg       Date:  2008-06       Impact factor: 5.115

View more
  3 in total

1.  Early spontaneous occlusion of a vertebral artery dissecting aneurysm caused by subarachnoid hemorrhage: A case report.

Authors:  Yoshio Suyama; Ichiro Nakahara; Shoji Matsumoto; Jun Morioka; Akiko Hasebe; Jun Tanabe; Sadayoshi Watanabe; Kenichiro Suyama; Kiyonori Kuwahara
Journal:  Radiol Case Rep       Date:  2022-04-08

2.  Flow Diversion for Reconstruction of Intradural Vertebral Artery Dissecting Aneurysms Causing Subarachnoid Hemorrhage-A Retrospective Study From Four Neurovascular Centers.

Authors:  Jens Maybaum; Hans Henkes; Marta Aguilar-Pérez; Victoria Hellstern; Georg Alexander Gihr; Wolfgang Härtig; André Reisberg; Dirk Mucha; Marie-Sophie Schüngel; Richard Brill; Ulf Quäschling; Karl-Titus Hoffmann; Stefan Schob
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

3.  Endovascular treatment of vertebral artery dissecting aneurysm: A single-center experience.

Authors:  Xintong Zhao; Huifang Wang; Jiaqiaing Liu; Zihuan Zhang; Zhenbao Li
Journal:  Exp Ther Med       Date:  2019-10-25       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.